• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Valeo Pharma Appoints President, COO

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Cognate BioServices Announces Major Expansion

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    Virtual Clinical Trials: The Future of Dermatology Studies

    Cognate BioServices Announces Major Expansion
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Flow Sciences

    Cytovance Biologics

    Adare Pharma Solutions

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Syngene

    Reed-Lane

    Adare Pharma Solutions

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Angelini Pharma Acquires Arvelle Therapeutics for $960M

    Angelini to become a leader in CNS and mental health disorder treatments; opening direct affiliates in France, UK, Nordics and Switzerland by 2022.

    Angelini Pharma Acquires Arvelle Therapeutics for $960M
    Angelini will have the exclusive license to commercialize CNS treatment cenobamate in the EU.
    Related CONTENT
    • Virtual Clinical Trials: The Future of Dermatology Studies
    • Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
    • RheinCell Therapeutics Achieves GMP Certification
    • Almac Sciences Secures Support from Invest NI
    • Drug Product Development, Manufacturing, and Packaging
    Contract Pharma Staff01.05.21
    Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini Group, and Arvelle Therapeutics, a Swiss-based biopharma focused on central nervous system (CNS) disorders, have concluded a definitive merger agreement under which Angelini Pharma will acquire Arvelle Therapeutics for up to $960 million. Following regulatory approval, $610 million will be paid. Subsequently, and subject to cenobamate reaching certain revenue targets, a further $350 million will be paid.
     
    Following Angelini Pharma’s acquisition of Arvelle Therapeutics, Angelini Pharma will have the exclusive license to commercialize cenobamate in the EU and other countries in the European Economic Area (Switzerland and the UK). Angelini plans to launch cenobamate after receiving approval from the European Medicines Agency (EMA), which is expected in 2021.
     
    Since its founding in 2019, Arvelle’s management team has focused on bringing cenobamate to people with epilepsy in Europe. They have worked in close collaboration with the European regulators to advance the marketing authorization application (MAA), and they have successfully prepared for launch by building an organization throughout Europe and ensuring launch readiness across key areas of the business.
     
    Cenobamate is a Promising Innovative Medicine by the UK’s MHRA for the treatment of drug-resistant focal-onset seizures in adults. Cenobamate is a small molecule with a unique dual complementary mechanism of action. It acts positively modulating the γ-aminobutyric acid (GABAA) ion channel and inhibiting voltage-gated sodium currents. Key study findings documented cenobamate’s clinical efficacy by showing a significant greater reduction in median seizure frequency and more patients achieving a 50% or greater reduction in seizure frequency compared to the placebo group. Cenobamate is approved by the Food and Drug Administration (FDA) in the United States as an anti-seizure medication (ASM) for the treatment of partial-onset (focal-onset) seizures in adults, and is available under the brand name XCOPRI (cenobamate tablets) CV.
     
    "It’s the most important investment in the history of our Group and it is the confirmation of the shareholder's commitment to pharma, which remains our biggest business,” said Sergio Marullo di Condojanni, chief executive officer, Angelini Holding. “This acquisition represents a milestone in our growth path as it definitively drives us towards the multinational dimension, to which all the companies of Angelini Group are now looking at. We are proud that, for the second time in a year, we have managed to win a significant and coveted asset, which strengthens and positions us among the most important players in the market.”
     
    Pierluigi Antonelli, chief executive officer, Angelini Pharma, said, “At Angelini Pharma, we are thrilled to sign this promising agreement and are enthusiastic about the commitment and work that our colleagues at Arvelle have put into the business during the last years. We share the same patient-centric culture and agility attitude. This transaction will propel us into a leading European player, well positioned to address the needs of patients with different Central Nervous System (CNS) disorders through an innovative portfolio, distinctive medical capabilities and extensive commercial presence, also via the opening of direct affiliates in France, UK, Nordics and Switzerland by 2022.”
     
    “I am very proud of the team we have built at Arvelle and the progress we have made over the last two years in helping bring cenobamate to people suffering with epilepsy in Europe” said Mark Altmeyer, president and chief executive officer, Arvelle Therapeutics. “We think there is an excellent strategic fit with Angelini Pharma and believe the acquisition of Arvelle, and the launch of cenobamate can help accelerate their goal of becoming a leading CNS industry player.”
     
    Suggested For You
    The Future of Clinical Trials Series: Part I The Future of Clinical Trials Series: Part I
    Virtual Clinical Trials: The Future of Dermatology Studies Virtual Clinical Trials: The Future of Dermatology Studies
    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
    RheinCell Therapeutics Achieves GMP Certification RheinCell Therapeutics Achieves GMP Certification
    Almac Sciences Secures Support from Invest NI Almac Sciences Secures Support from Invest NI
    Drug Product Development, Manufacturing, and Packaging Drug Product Development, Manufacturing, and Packaging
    Baxter, Novavax Ink Sterile Manufacturing Agreement Baxter, Novavax Ink Sterile Manufacturing Agreement
    Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
    The Alcami Advantage The Alcami Advantage
    Aurigene Pharmaceutical Services ltd. Aurigene Pharmaceutical Services ltd.
    Parexel Appoints Chief Patient Officer Parexel Appoints Chief Patient Officer
    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021 The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    February 4-11, 2021: Auction of Equipment – Major Nutraceutical Softgel Manufacturer February 4-11, 2021: Auction of Equipment – Major Nutraceutical Softgel Manufacturer
    Aceto to Acquire IsleChem Aceto to Acquire IsleChem
    Impact of Decentralized Trials in Oncology Drug Development Impact of Decentralized Trials in Oncology Drug Development

    Related Breaking News

    • Promotions & Moves
      Valeo Pharma Appoints President, COO

      Valeo Pharma Appoints President, COO

      Frederic Fasano brings 25 years of experience to the newly created position.
      Contract Pharma Staff 01.18.21

    • Breaking News | Collaborations & Alliances | Drug Discovery
      Metrion, LifeArc Extend Neuroscience Alliance

      Metrion, LifeArc Extend Neuroscience Alliance

      Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.
      Contract Pharma Staff 01.18.21

    • Breaking News | Clinical Trials | Industry News
      Grifols Begins COVID-19 Plasma Treatment Trial

      Grifols Begins COVID-19 Plasma Treatment Trial

      Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.
      Contract Pharma Staff 01.18.21


    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
      Janssen, TenNor Enter NTM Research Pact

      Janssen, TenNor Enter NTM Research Pact

      To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.
      Contract Pharma Staff 01.18.21

    • Breaking News | Industry News
      KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

      KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

      New lineup aims to address challenges from early stage powder characterization and formulation development to scale-up and production.
      Contract Pharma Staff 01.15.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Cognate BioServices Announces Major Expansion

      Cognate BioServices Announces Major Expansion

      Will increase cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities and more.
      Contract Pharma Staff 01.15.21


    • Breaking News | Collaborations & Alliances | CRO News | Industry News
      Bioclinica Partners with Ikcon Pharma

      Bioclinica Partners with Ikcon Pharma

      Will work together to deliver best-in-class e-clinical solutions to the pharma industry & sponsors.
      Contract Pharma Staff 01.15.21

    • Breaking News | Clinical Trials | CRO News | Industry News
      Frontage Bolsters Clinical Services Capabilities

      Frontage Bolsters Clinical Services Capabilities

      Unveils plans to provide full service human radiolabeled absorption, metabolism, and excretion study capabilities.
      Contract Pharma Staff 01.15.21

    • APIs | Breaking News | Facilities | Industry News
      Sanofi Unveils EUROAPI as Name of New European API Company

      Sanofi Unveils EUROAPI as Name of New European API Company

      Appoints Karl Rotthier as its future Chief Executive Officer.
      Contract Pharma Staff 01.15.21


    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Thermo Fisher Buys Novasep

      Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

      Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.
      Contract Pharma Staff 01.15.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Precision Medicine Group Acquires Project Farma

      Precision Medicine Group Acquires Project Farma

      Adds Project Farma's unique expertise to Precision's suite of end-to-end cell and gene therapy capabilities to support development and commercialization.
      Contract Pharma Staff 01.14.21

    • Breaking News | Collaborations & Alliances
      Charles River Partners with JADE

      Charles River Partners with JADE

      Expands its biologics testing capabilities geographically and helps to accommodate demand for biologics therapeutics.
      Contract Pharma Staff 01.14.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Cytiva Delivers Modular Biologics Factory to Lonza

      Cytiva Delivers Modular Biologics Factory to Lonza

      Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region.
      Contract Pharma Staff 01.14.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

      Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

      FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.
      Contract Pharma Staff 01.14.21

    • APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      LSNE Expands Fill Finish and Lyophilization Ops

      LSNE Expands Fill Finish and Lyophilization Ops

      New automated fill line at Bedford Campus adds ready-to-use aseptic filling and freeze-dryer capacity.
      Contract Pharma Staff 01.14.21

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • Tonix And Fujifilm Enter COVID-19 Vax Deal
    • Virtual Clinical Trials: The Future Of Dermatology Studies
    • Sanofi Unveils EUROAPI As Name Of New European API Company
    Breaking News
    • Valeo Pharma Appoints President, COO
    • Metrion, LifeArc Extend Neuroscience Alliance
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Janssen, TenNor Enter NTM Research Pact
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Maternal Dietary Intake of Fish, Omega-3s, and Omega-6s Linked to Child Neurodevelopment
    Short Term Low-Carb Diet Linked to Remission of Type 2 Diabetes
    Brown Fat Associated with Reductions in Chronic Disease Risk
    Coatings World

    Latest Breaking News From Coatings World

    Huntsman Finalizes Acquisition of Gabriel Performance Products
    PPG Completes COLORFUL COMMUNITIES Project at School in A. Bangsaothong Samutprakarn, Thailand
    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FineHeart Successfully Tests Wireless TET System
    Apria Healthcare Settles Whistleblower Lawsuit
    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valeo Pharma Appoints President, COO
    Metrion, LifeArc Extend Neuroscience Alliance
    Grifols Begins COVID-19 Plasma Treatment Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    JLo Beauty Launches at Sephora & Amazon
    Unilever and Alibaba Group Join Forces
    Redken Unveils Acidic Bonding Concentrate Range
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    Manscaped Expands Further in Europe
    Color Street Gives Back
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ontex Honored for Mask Production
    TFP Acquires PV3 Technologies
    Shemesh Adds U.S. Headquarters
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoPediatrics Expands Agent Network in Three European Countries
    Studies Show FlareHawk Expandable Cage Delivers Favorable Fusion, Patient Outcomes
    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login